Abstract
Dopamine neurons are characterized by their response to unexpected rewards, but they also fire during movement and aversive stimuli. Dopamine neuron diversity has been observed based on molecular expression profiles; however, whether different functions map onto such genetic subtypes remains unclear. In this study, we established that three genetic dopamine neuron subtypes within the substantia nigra pars compacta, characterized by the expression of Slc17a6 (Vglut2), Calb1 and Anxa1, each have a unique set of responses to rewards, aversive stimuli and accelerations and decelerations, and these signaling patterns are highly correlated between somas and axons within subtypes. Remarkably, reward responses were almost entirely absent in the Anxa1 + subtype, which instead displayed acceleration-correlated signaling. Our findings establish a connection between functional and genetic dopamine neuron subtypes and demonstrate that molecular expression patterns can serve as a common framework to dissect dopaminergic functions.
Original language | English (US) |
---|---|
Pages (from-to) | 1762-1774 |
Number of pages | 13 |
Journal | Nature neuroscience |
Volume | 26 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2023 |
Funding
We thank everyone who provided advice and critiques on this manuscript: T. S. Hnasko, J. B. Issa, Y. Kozorovitskiy, S. Lammel, A. Miri, J. Y. Oh, J. G. Parker, D. J. Surmeier and F. Xuan. We also thank D. Raj for coordination of Aligning Science Across Parkinson’s compliance. This work was funded by Aligning Science Across Parkinson’s (ASAP-020600) through the Michael J. Fox Foundation for Parkinson’s Research (MJFF) (R.A. and D.A.D). For the purpose of open access, the authors have applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission. This work was also supported by grants from the National Institutes of Health (R01MH110556, R.A. and D.A.D.; National Institute of Neurological Disorders and Stroke (NINDS) 1R01NS119690-01, R.A.; National Institute on Drug Abuse P50 DA044121-01A1, R.A.; NINDS 1F31NS115524-01A1, Z.G.; National Institute of General Medical Sciences 5T32GM008152-34, Z.G.; National Cancer Institute CA060553, core support; 1S10OD025120, core support; 1S10OD011996-01, equipment and 1S10OD026814-01, equipment) and from La Caixa Fellowship (M.A.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the paper.
ASJC Scopus subject areas
- General Neuroscience